Skip to main content
. 2017 May 10;14(1):313–321. doi: 10.3892/ol.2017.6145

Table I.

Associations between ABCB1, ALDH1A1 and CD44 expression levels and characteristics of patients with lung adenocarcinoma.

ABCB1 expression ALDH1A1 expression CD44 expression



Variables Total no. (%) Positive [no. (%)] Negative [no. (%)] P-value Positive [no. (%)] Negative [no. (%)] P-value Positive [no. (%)] Negative [no. (%)] P-value
No. of cases 128 (100) 20 (16) 108 (84) 43 (34) 85 (66) 67 (52) 61 (48)
Age, years 0.40 0.03 0.38
  <65   47 (37)   9 (19)   38 (81) 10 (21) 37 (79) 27 (57) 20 (43)
  ≥65   81 (63) 11 (14)   70 (86) 33 (41) 48 (59) 40 (49) 41 (51)
Sex 0.22 0.09 0.16
  Male   67 (52) 13 (19)   54 (81) 27 (40) 40 (60) 39 (58) 28 (42)
  Female   61 (48)   7 (11)   54 (89) 16 (26) 45 (74) 28 (46) 33 (54)
Tobacco smoking 0.84 0.97 0.08
  Yes   80 (63) 13 (16)   67 (84) 27 (34) 53 (66) 47 (59) 33 (41)
  No   47 (37)   7 (15)   40 (85) 16 (34) 31 (66) 20 (43) 27 (57)
  Unknown   1 (1) 0 (0)   1 (1) 0 (0) 1 (1) 0 (0) 1 (1)
Grade 0.18 0.01 0.13
  1   42 (17)   4 (10)   38 (90)   7 (17) 35 (83) 26 (62) 16 (38)
  2+3   86 (83) 16 (19)   70 (81) 36 (42) 50 (58) 41 (48) 45 (52)
T stage 0.36 0.56 0.02
  T1   40 (31)   8 (20)   32 (80) 12 (30) 28 (70) 27 (68) 13 (33)
  T2+T3   88 (69) 12 (14)   76 (86) 31 (35) 57 (65) 40 (45) 48 (55)
N stage 0.51 0.81 0.36
  N0   91 (71) 13 (14)   78 (86) 30 (33) 61 (67) 50 (55) 41 (45)
  N1+N2   37 (29)   7 (19)   30 (81) 13 (35) 24 (65) 17 (46) 20 (54)
Pathological stage 0.89 0.76 0.02
  I   75 (59) 12 (16)   63 (84) 26 (35) 49 (65) 46 (61) 29 (39)
  II+III   53 (41)   8 (15)   45 (85) 17 (32) 36 (68) 21 (40 32 (60)
EGFR mutation status 0.55 0.47 0.32
  Positive   28 (22)   4 (14)   24 (86) 11 (39) 17 (61) 17 (61) 11 (39)
  Negative 100 (78) 16 (16)   84 (84) 32 (32) 68 (68) 50 (50) 50 (50)

ABCB1, ATP binding cassette subfamily B member 1; ALDH1A1, aldehyde dehydrogenase 1 family member A1; CD, cluster of differentiation; EGFR, epidermal growth factor receptor.